2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

“This is very important because fainting impacts thousands of people every day. Now that we have these guidelines, physicians and clinicians will be able to make better-informed decisions and this will contribute to improved patient outcomes.”

“Syncope occurs in thousands of patients every day. One third to half of the US population have had syncope at some point in their lifetime. Additionally, syncope is a symptom that can be associated with many different conditions, some of them benign; however, it is critically important to exclude any serious causes.”

“The new ACC/AHA/HRS syncope guidelines were published to drive better informed clinical decisions and improved patient outcomes. Patients who have experienced frequent symptoms may benefit the most from a short-term external heart monitor such as the Seeq Mct System. Patients who experience less frequent symptoms – more than 30 days between symptoms – may be better suited for long-term cardiac monitors such as the Reveal Linq implantable cardiac monitors with Trurhythm Detection, which can monitor the heart for up to three years.”